Van Tai Nguyen

10PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsOther environmental sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 13, 2026
Efficacy of Pembrolizumab as a Second- or Third-Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Multicenter Retrospective Study in Vietnamese Patients.

|May 06, 2026
Real-World Outcomes of Mantle Cell Lymphoma Treated With Rituximab-Based Chemotherapy Regimens: Experience From a Single Institution in Vietnam.

|Oct 21, 2025
Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam.

Cam Phuong Pham, Hung Kien Do, Anh Tu Do

|Aug 11, 2025
Effectiveness of Second-Line Pembrolizumab Monotherapy for the Treatment of Nonsmall Cell Lung Cancer: A Retrospective-Single Institution Study of 52 Vietnamese Patients.

Van Tai Nguyen, Hung Kien Do, Quang Van Le

|Aug 26, 2024
Histopathological Response to Neoadjuvant Chemotherapy in Patients With Enneking Stage II Conventional Osteosarcoma of Extremities: A Retrospective-Single Institution Study in Vietnam.

Kien Hung Do, Tai Van Nguyen, Trang Thu Hoang

|May 18, 2024
Anti-Angiogenic Tyrosine Kinase Inhibitor-Related Toxicities Among Cancer Patients: A Systematic Review and Meta-Analysis.

Tai Van Nguyen, Diaddin Hamdan, Géraldine Falgarone

Pageof 2

Frequent Collaborators

5 joint publications

Kien Hung Do

3 joint publications

Chu Van Nguyen

2 joint publications

Thi Bich Phuong Nguyen

2 joint publications

Duc Thanh Le